SCHEMBL27866895

SCHEMBL27866895

O=CC1CC(CO)CN1Cc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 1/20 0.43
▸ GBA1 P04062 2/20 0.41
▸ DRD2 P14416 9/20 0.40
▸ DRD3 P35462 9/20 0.40
▸ DRD1 P21728 5/20 0.39
▸ CYP2D6 P10635 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28007890 0.86 MAPT (0.41) MAPT
SCHEMBL21704250 0.80 MAPT (0.50) MAPTGBA1CYP2D6
SCHEMBL2271581 0.78 MAPT (0.65) MAPTGBA1DRD2DRD3
SCHEMBL3601179 0.78 MAPT (0.65) MAPTGBA1DRD2DRD3
SCHEMBL17048017 0.78 MAPT (0.65) MAPTGBA1DRD2DRD3
SCHEMBL3597729 0.78 MAPT (0.65) MAPTGBA1DRD2DRD3
SCHEMBL3601182 0.78 MAPT (0.65) MAPTGBA1DRD2DRD3
SCHEMBL3597725 0.78 MAPT (0.65) MAPTGBA1DRD2DRD3
SCHEMBL28046374 0.77 HPGD (0.48) MAPTDRD2DRD3DRD1
SCHEMBL4058697 0.77 GBA1 (0.47) GBA1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102432525-A Practical synthesis method of 3-benzyl-3-azabicyclo [2,1,0] hexane SUZHOU KANGRUN PHARMACEUTICALS INC 2012-05-02 — — CN claimed
CN-104402791-B Preparation method for nebracetam 河南师范大学 2017-02-01 — — CN disclosed
CN-104402791-B Preparation method for nebracetam 河南师范大学 2017-02-01 — — CN disclosed
CN-104402791-A Preparation method for nebracetam UNIV HENAN NORMAL 2015-03-11 — — CN disclosed
CN-102432525-A Practical synthesis method of 3-benzyl-3-azabicyclo [2,1,0] hexane SUZHOU KANGRUN PHARMACEUTICALS INC 2012-05-02 — — CN disclosed
Send feedback